Preetam Shah Cidara Therapeutics, Inc. (CDTX) insider trading activity
Preetam Shah is Chief Financial Officer of Cidara Therapeutics, Inc.. Currently has a direct ownership of 335,960 shares of CDTX, which is worth approximately $4.5 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 108,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
336K
0%
3M change
41.08%
12M change
Total Value Held
$4.5 Million
Preetam Shah Transaction History
Also insider at
PS
Preetam Shah
Chief Financial Officer
San Diego, CA